CareCloud Inc. is facing a regulatory issue following the passing of independent director John N. Daly on November 24, 2025. The company notified Nasdaq that, as a result, it no longer complies with Nasdaq Listing Rules requiring a majority of independent directors on its Board and at least three members on its Audit Committee. Nasdaq has granted CareCloud a cure period until its next annual shareholder meeting or November 24, 2026, whichever comes first, to restore compliance by appointing a new independent director. The company has stated its intention to fill the vacancy and regain compliance as soon as possible.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CareCloud Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-025178), on November 26, 2025, and is solely responsible for the information contained therein.